A Mobile Health Intervention to Reduce Sweet Beverage Consumption in Latino Children
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Feb 10, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help Latino children aged 1 to 5 drink fewer sugary beverages and to encourage parents to read aloud to their children more often. Drinking too many sugary drinks can lead to serious health issues like obesity and diabetes, and many Latino children are at a higher risk for these problems. The study aims to see if two mobile health programs can help parents improve their children's drink choices and increase the amount of reading done at home.
To participate in this study, parents must identify their child as Latino and have a child between 1 to 5 years old. They also need to have a cell phone that can receive text messages and be able to speak either English or Spanish. Throughout the trial, families will receive helpful tips and support through their phones to make these positive changes. This is a great opportunity for families to contribute to important research while also gaining tools to promote healthier habits and early literacy in their children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent identifies child as Latino/a/x
- • Child age 1 to 5 (12 to 59 months)
- • Parent has a cell phone that can receive text messages
- • Parent speak English or Spanish
- Exclusion Criteria:
- • • Child does not feed by mouth
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Amy L Beck, MD, MPH
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials